Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Laura Rodriguez-Osorio"'
Autor:
Ricardo Villa-Bellosta, Laura Rodriguez-Osorio, Sebastian Mas, Younes Abadi, Mercedes Rubert, Concepción de la Piedra, Carolina Gracia-Iguacel, Ignacio Mahillo, Alberto Ortiz, Jesús Egido, Emilio González-Parra
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0173831 (2017)
BACKGROUND:The mortality of dialysis patients is 10- to 100-fold higher than in the general population. Baseline serum PTH levels, and more recently, changes in serum PTH levels (ΔPTH) over time, have been associated to mortality in dialysis patient
Externí odkaz:
https://doaj.org/article/daa11f61f33b4c6c88604467809576d4
Autor:
María Dolores, Arenas Jimenez, Angel, Méndez, Karina, Furaz, Ana, Botella, Delfina, Yetman, Ramiro, Cazar, Mara Lisbet, Cabana, Marc, Handel, María Luz, Sanchez, Margarita, Delgado, Maria Melissa, Vasquez, Isabel, Martinez, Monica, Pereira, Emilio, González-Parra, Maria Soledad, Pizarro-Sánchez, Ignacio Sanz, Garayzabal, Laura, Rodriguez-Osorio, José, Portoles, David, Hernán, Blanca, Miranda, Concepción Ferreira, Feijoo
Publikováno v:
Clinical Kidney Journal. 15:1340-1347
Background The coronavirus disease (COVID) pandemic has resulted in a major disruption in healthcare that has affected several medical and surgical specialties. European and American Vascular Societies have proposed deferring the creation of an elect
Autor:
Marco Chiaravalli, Miguel A. Garcia-Gonzalez, Diego Martin-Sanchez, Patricia Outeda, Olaya Lamas-Gonzalez, Candido Diaz, Maria Vanessa Perez-Gomez, Laura Rodriguez-Osorio, Terry Watnick, Alessandra Boletta, Alberto Ortiz, Ana Belen Sanz, Laura Nuñez-Gonzalez, Adrián Cordido, Julio M. Martinez-Moreno, Angel Carracedo
Publikováno v:
J Am Soc Nephrol
Background In autosomal dominant polycystic kidney disease (ADPKD), cyst development and enlargement lead to ESKD. Macrophage recruitment and interstitial inflammation promote cyst growth. TWEAK is a TNF superfamily (TNFSF) cytokine that regulates in
Autor:
Jesús Egido, Carolina Gracia-Iguacel, Concepción de la Piedra, M. Rubert, María Luisa González Casaus, Emilio González Parra, Laura Rodriguez-Osorio, Marta Martín-Fernández, Ricardo Villa-Bellosta
Publikováno v:
Nefrología (English Edition), Vol 37, Iss 4, Pp 389-396 (2017)
Nefrología (Madrid), Volume: 37, Issue: 4, Pages: 389-396, Published: AUG 2017
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Nefrología (Madrid), Volume: 37, Issue: 4, Pages: 389-396, Published: AUG 2017
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Parathormone plays a key role in controlling mineral metabolism. PTH is considered a uremic toxin causing cardiovascular damage and cardiovascular mortality in dialysis patients. There are two different assays to measure PTH called 2nd generation or
Autor:
M. Rubert, María Luisa González Casaus, Emilio González Parra, Marta Martín-Fernández, Ricardo Villa-Bellosta, Carolina Gracia-Iguacel, Laura Rodriguez-Osorio, Jesús Egido, Concepción de la Piedra
Publikováno v:
Nefrología, Vol 37, Iss 4, Pp 389-396 (2017)
Nefrología (Madrid) v.37 n.4 2017
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Nefrología (Madrid) v.37 n.4 2017
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Resumen La paratohormona tiene un papel fundamental en el control del metabolismo mineral. Ademas es considerada como una toxina uremica al originar dano cardiovascular e influir en la mortalidad cardiovascular del paciente en dialisis. Existen dos m
Autor:
Elena Corchete Prats, Emilio González-Parra, Almudena Vega, Nicolás Macías, María Delgado, Milagros Fernández, Rafael Jesús Sánchez, Laura Álvarez, Ramón Jesús Miranda, Javier Vian, Virginia López, Evangelina Mérida, Mónica Pereira, David Sapiencia, Natalia Andrés, Patricia Muñoz, Yohana Gil, María Sánchez, Clara Cases, Beatriz Gil, Alicia García, Valeria Sainz, Simona Alexandru, Saúl Pampa, María López, José Carlos de la Flor, Patricia Nora Estrada, José Ramón Berlanga, Rocío Zamora, Rosa Sánchez, Laura Rodríguez-Osorio, Carmen Fraile, Fernando Caravaca-Fontán, Cristina Moratilla, Carmen Cabré, Karina Furaz, Luis Nieto, María Teresa Villaverde, Claudia Grisel Tapia, Santiago Cedeño, Sandra Castellano, Evaristo Valdés, Marta Ferreira, Pilar Martínez, Marta Sanz, Mercedes Sánchez, Francisco Ríos, Sofía Palomo, María Luisa Serrano, Ana Blanco, Laura Espinel, Fernando Tornero, Jose Antonio Herrero
Publikováno v:
Nefrología (English Edition), Vol 43, Iss 4, Pp 435-441 (2023)
This study screened for Fabry disease (FD) in patients in hemodialysis (HD) in the region of Madrid (CAM) with a cross-sectional design to evaluate HD-prevalent patients, followed by a three-year period prospective design to analyze HD-incident patie
Externí odkaz:
https://doaj.org/article/b32184ec70024cedb867c02ac15d7fa6
Autor:
Clara Bonanad, Juan M. Buades, Juan Pablo Leiva, Rafael De la Espriella, Marta Cobo Marcos, Julio Núñez, Helena García-Llana, Lorenzo Facila, Rosa Sánchez, Laura Rodríguez-Osorio, Alberto Alonso-Babarro, Borja Quiroga, Daznia Bompart Berroteran, Carmen Rodríguez, Daniela Maidana, Javier Díez
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
There is an unmet need to create consensus documents on the management of cardiorenal patients since, due to the aging of the population and the rise of both pathologies, these patients are becoming more prevalent in daily clinical practice. Chronic
Externí odkaz:
https://doaj.org/article/7bd620f5e1874408b2d9fef227445821
Autor:
Alberto Ortiz, Laura Rodriguez-Osorio
Publikováno v:
Clinical Kidney Journal
Eculizumab is an anti-C5 antibody that inhibits C5 cleavage and prevents the generation of the terminal complement complex C5b-9. Eculizumab is licensed to treat paroxysmal nocturnal haemoglobinuria or atypical haemolytic uraemic syndrome (aHUS). Cli
Autor:
Ana Belen Sanz, Maria Dolores Sanchez-Niño, Laura Rodriguez-Osorio, Marta Ruiz-Ortega, Alberto Ortiz, Cristian González-Guerrero, Catalina Martin-Cleary, Beatriz Fernandez-Fernandez, Adrian M. Ramos
Publikováno v:
Expert Opinion on Drug Discovery. 10:541-556
Kidney disease remains one of the last worldwide frontiers in the field of non-communicable human disease. From 1990 to 2013, chronic kidney disease (CKD) was the top non-communicable cause of death with a greatest increase in global years of life lo
Autor:
Alberto Ortiz, Emilio González Parra, Carolina Gracia-Iguacel, Laura Rodriguez-Osorio, Jesús Egido, Diana Pazmiño Zambrano, Jorge Rojas-Rivera
Publikováno v:
Nefrología, Vol 35, Iss 2, Pp 207-217 (2015)
Nefrología (Madrid) v.35 n.2 2015
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Nefrología (Madrid) v.35 n.2 2015
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
ResumenEl sevelamer es un captor no cálcico de fósforo que se utiliza en la ERC avanzada y en diálisis para el control de la hiperfosforemia. Varios estudios experimentales, observacionales y ensayos clínicos han mostrado que el sevelamer tiene e